Ayush Ministry Gets Rs 3,712 Crore In Interim Budget

New Delhi: The interim Budget allocation for the Ayush Ministry has been increased to Rs 3,712.49 crore for 2024-25 from Rs 3,000 crore (revised estimates) in 2023-24, recording a rise of 23.74 percent.

The National Medicinal Plants Board has been allocated Rs 14.63 crore while the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) allocated Rs 20.80 crore.

The autonomous bodies have been allocated Rs 1,848.40 crore, of which Central Council for Research in Ayurvedic Sciences has been given Rs 413.54 crore, Central Council for Research in Homeopathy Rs 144 crore, Central Council for Research in Unani Medicine Rs 228.05 crore and the All India Institute of Ayurveda has got Rs 227.20 crore.

The National Medicinal Plants Board undertakes promotional and contractual farming schemes with a view to encourage in-situ conservation and ex-situ cultivation of medicinal plants for providing raw materials of assured quality for manufacturing of ASU&H medicines.

At the initiative of the National Medicinal Plants Board, 32 State Medicinal Plants Boards in 27 states and five Union territories have been constituted for providing impetus to cultivation of high priority medicinal plants for domestic consumption as well as export.

The Pharmacopoeia Commission for Indian Medicine and Homoeopathy is a subordinate office under the Ministry of Ayush. It is an appellate authority for drug testing of all Ayush drugs in India. Further, it sets standards for all Ayush drugs which are published in the form of Pharmacopoeias.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit